OOIR: Observatory of International Research

Papers

(The H4-Index of FEBS Journal is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
A guide to the composition and functions of the extracellular matrix	316
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study	289
A guide to assessing cellular senescence in vitro and in vivo	247
Glycolysis – a key player in the inflammatory response	240
Rab family of small GTPases: an updated view on their regulation and functions	215
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2	182
Signaling pathways and defense mechanisms of ferroptosis	166
A guide to plasma membrane solute carrier proteins	163
A guide to: generation and design of nanobodies	149
Multifunctional intracellular matrix metalloproteinases: implications in disease	142
New insights into the activities and toxicities of the old anticancer drug doxorubicin	139
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing	131
ADP‐ribosyltransferases, an update on function and nomenclature	129
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics	124
Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts	121
The structural basis of accelerated host cell entry by SARS‐CoV‐2†	107
Resistin in metabolism, inflammation, and disease	106
Exosomes as mediators of immune regulation and immunotherapy in cancer	103
The ECM path of senescence in aging: components and modifiers	100
Discovery, development, and future application of senolytics: theories and predictions	99
Sympathetic activation: a potential link between comorbidities and COVID‐19	95
Calnexin cycle – structural features of the ER chaperone system	93
A guide to the regulation of selective autophagy receptors	87
More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization	82
Evolution of new enzymes by gene duplication and divergence	80

Cellular senescence: all roads lead to mitochondria	71
Is nicotine exposure linked to cardiopulmonary vulnerability to COVID‐19 in the general population?	70
Hallmarks of the aging T‐cell system	70
The mitochondrial permeability transition: Recent progress and open questions	67
The role of PARP1 in neurodegenerative diseases and aging	67
A guide to the Michaelis–Menten equation: steady state and beyond	65
AMPK, metabolism, and vascular function	61
Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID‐19 patients	60
Transposable element regulation and expression in cancer	59
Global functions of O‐glycosylation: promises and challenges in O‐glycobiology	58
The role of structural dynamics in GPCR‐mediated signaling	57
The blood–retina barrier in health and disease	55
Revisiting sORFs: overcoming challenges to identify and characterize functional microproteins	55
Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise	55
The multifaceted role of TRAIL signaling in cancer and immunity	54
Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease	54
Human transfer RNA modopathies: diseases caused by aberrations in transfer RNA modifications	54
Nrf2 and oxidative stress in liver ischemia/reperfusion injury	54
Immunogenicity and humanization of single‐domain antibodies	53
Epithelial‐to‐mesenchymal‐like transition events in melanoma	53
Targeting dormant tumor cells to prevent cancer recurrence	52
Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme	52
Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage‐gated calcium channels and NADPH oxidase	51
Oxygen‐sensing mechanisms in cells	50
Protein S‐Palmitoylation: advances and challenges in studying a therapeutically important lipid modification	49